Enteral antioxidants in ischemia/reperfusion injuries in rats by Köhler, Hugo Fontan et al.
422
Rev. Col. Bras. Cir. 2011; 38(6): 422-428
Köhler
Enteral antioxidants in ischemia/reperfusion injuries in ratsOriginal Article
Enteral antioxidants in ischemia/reperfusion injuries in rats
Antioxidantes enterais em lesões de isquemia e reperfusão em ratos
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A B S T R A C T
Objective: To evaluate the role of pre-treatment with dietary antioxidants in an experimental model of intestinal injury of
ischemia-reperfusion (I/R) in rats. Methods: Ninety adult male Wistar rats were used. An intestinal segment was isolated based
on its vascular pedicle. A control biopsy was performed and the pedicle was sectioned and sutured again, ensuring a time of
60 minutes of ischemia followed by reperfusion. Sequential biopsies were performed at the end of the ischemic period and
every 15 minutes during reperfusion. The treatment consisted of saline, vitamin C, vitamin E or a combination of the latter two.
Quantitative and qualitative assessments of the biopsies were performed. Results: The groups treated with vitamin E alone
or vitamin E combined with vitamin C showed a statistically significant attenuation of ischemia-reperfusion, with reduced loss
of height of the villi and lower neutrophilic infiltration at the end of the study when compared to the control and vitamin C-
exclusive groups. Conclusion: In this experimental model of ischemia-reperfusion, pre-treatment with vitamin E attenuated
the I/R injury in the small intestine of Rats, demonstrated by reduced loss of height of the villi and the attenuation of neutrophil
infiltration.
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INTRODUCTION
The restoration of blood flow to an ischemic tissue canlead to greater harm than that originally caused by
ischemia. This event is called ischemia and reperfusion
(I/R) injury. The small intestine is particularly susceptible
to injury from I/R1 and its occurrence is associated with
high morbidity and mortality2. Although the mechanisms
involved are not fully elucidated, it is believed that
oxidative stress mediators, such as reactive oxygen
species (ROS), polymorphonuclear neutrophils (PMN) and
nitric oxide (NO) play an important role3. Due to the
involvement of ROS in I/R injury, various antioxidants have
been tested, among them vitamin C (ascorbic acid) and
vitamin E. Ascorbic acid is an water-soluble antioxidant
with chelating and reducing properties and it is used to
prevent I/R injury4. Vitamin E (á-tocopherol) is a non-
enzymatic, lipid soluble antioxidant that acts against
oxidative stress by stabilizing membrane unsaturated fatty
acids. Thus, tissues treated with vitamin E have an
increased capacity to reduce ROS and be protected
against membrane lipid peroxidation5. Vitamins C and E
can act synergistically because ascorbic acid is unable to
reduce the peroxyl radical, but it can regenerate á-
tocopherol from the tocoferoxil radical, recycling the á-
tocopherol6.
I/R can occur in a variety of clinical situations,
one being the microsurgical transfer of jejunal segments.
The jejunal flap was first described in 1957, and has been
used for reconstruction of the pharynx and esophagus. During
the transfer, an isolated segment of jejunum is removed
from the abdomen and transferred to the neck7. In the
clinical setting, I/R injury can be seen ten minutes after
reperfusion, with gradual recovery until the 28th day8.
The objective of this study is to evaluate the
impact of pre-treatment with vitamins C and E in an expe-
rimental model of jejunal flap using morphometric criteria
to assess I/R injury.
METHODS
Model of jejunal ischemia-reperfusion
Was used 90 adult male Wistar rats between 224
and 261 grams of weight (average of 237.5g and standard
deviation (SD) of 12.3g) in the experiment. After anesthesia
with intraperitoneal ketamine and xylazine, the animals
were placed in the supine position on a warm table and
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underwent laparotomy. Body temperature was monitored
with a rectal probe to avoid hypothermia. The superior
mesenteric artery and vein were dissected and isolated from
their sources in sufficient length to allow placement of
vascular clamps and performance of sutures. The study area
was then selected according to the arterial supply to the
intestine. The first choice for biopsy was the sixth loop from
the ileocecal valve, the subsequent seventh loop being an
alternative. One fragment with a total thickness of the in-
testinal wall was removed and sent for biopsy control (BC).
In order to avoid variations in height of villi throughout the
intestine, a 3cm jejunal segment was dissected based on
its vascular pedicle and isolated by sectioning of any
collateral circulation to it. All the biopsy fragments were
obtained from this segment. In order to simulate a
microsurgical flap, a microvascular clamp was placed in
the mesenteric vessels that, soon after, were sectioned. A
microvascular anastomosis was then performed between
the stumps by using magnification Zeiss microscope and
10-0 nylon suture. After one hour of ischemia, during which
vascular anastomosis was performed, a second fragment
(ischemic biopsy - BI) was extracted and the clamps
removed, restoring blood flow. After removing the clamps,
there were four successive tissue removals: at 15 minutes
of reperfusion (RB15); at 30 minutes of reperfusion (RB30);
at 45 minutes of reperfusion (RB45); and at 60 minutes of
reperfusion (RB60). Each sample had a length of
approximately 0.4 cm and included the entire circumference
of the jejunal segment. To simulate the conditions of a
microvascular transfer, the segment chosen for the study
was kept outside the abdominal cavity, at room temperature
(24°C). All animals were euthanized after the procedure.
This experiment was approved by the Ethics
Committee on Animal Research of the Institute of Biology,
Universidade Estadual de Campinas.
Treatment groups
The animals were randomly divided into the
following groups, each with fifteen animals: Group T
underwent laparotomy with preparation of the flap without
ischemia and reperfusion; Control Group underwent
laparotomy, preparation of the flap, ischemia and
reperfusion, with collection of samples in predetermined
intervals, but received no treatment; Group C was submitted
to the same surgical procedure of the Control Group,
associated with the intake of ascorbic acid, 250mg/kg, via
enteral feeding for four days before the operation; Group E
underwent the same surgical procedure of the Control
Group, but received vitamin E at a dose of 60mg/kg in the
four days preceding the operation; Group C + E underwent
the same surgical procedure of the control group and
received both drugs, the same dose and Groups C and E
(250mg/kg of vitamin C and 60mg/kg vitamin E) for four
days; Validation Group C – Same as Group C, except that
during preparation of the drug , the active principle (ascorbic
acid) was removed; Validation Group E – Same as Group
E, with the active principle (a-tocopherol) removed during
preparation of the drug.
The purpose of Group T is to validate the model
and show that intestinal injury is not due to surgical
manipulation, but due to ischemia-reperfusion. Validation
Groups C and E are intended to demonstrate that the effect
of vitamins C and E was due to their active principles and
not to other components of the formula, which were kept
in the drugs administered to these animals as well as the
diluents.
Parameters of injury
Both qualitative and quantitative analyses were
used in the assessment of I/R injury. The height of the villi
and neutrophilic infiltration were evaluated in histological
sections of intestinal biopsies. All samples were evaluated
by the same histologist who was blinded to which group or
time of biopsy the animal belonged. The sections were
stained with routine histological techniques using
hematoxylin and eosin. The classification proposed by Chiu
et al.9 was used for qualitative assessment. The height of
villi was determined in ten random fields using an optical
system that allowed the measurement of height of the villus
in micrometers (mm). The neutrophil infiltration was
assessed by counting cells in 20 random fields.
Statistical analysis
Data are presented as mean and standard
deviation (SD). Spearman and Pearson tests were used to
evaluate the correlation between variables. A comparison
of multiple means was performed using analysis of variance
(ANOVA). If variances were equal, the Tukey test was used,
while the Dunnett test was applied to different variances.
A p value <0.05 was considered statistically significant. The




A progressive increase of I/R injury was observed
in all groups, with a significant migration from degree zero
to five over time, a statistically significant correlation
between time and Chiu score being demonstrated (Figure
1).
Height of villi
The height of the villi showed a progressive
decrease over the study period (Figure 2). A statistically
significant correlation was found between the biopsy
intervals and height of villi in all groups. The correlation
coefficient and p values   are shown in table 1.
Comparisons of height of the villi were performed
within each group at different intervals and also between
different groups within the same time interval. Initially, the
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Control Group was compared with those of validation. There
was no statistically significant difference between them at
any interval (Table 2). In the Control Group, the height of
villi decreased from 363.55 + / - 35.89 in BC to 129.16 + /
- 27.17 in RB60, and this decrease was statistically significant
(p <0.001). The first statistically significant difference was
observed in comparison with RB15, which showed height
of 296.87 + / - 46.13, p = 0.004 (Figure 2).
For Group C, a similar pattern was observed, with
the height of villi ranging from 336.61 + / - 44.63 in BC and
134.05 + / - 36.22 in RB60 (p <0.001), the RB15 being the
first biopsy presenting a significant difference, p <0.001
(Figure 2).
The animals treated with vitamin E had average
vilar height of 343.93 + / - 46.79 in CB and 154.12 + / -
31.88 in RB60 (p <0.001), but unlike the other, the first
significant difference was with BI, p <0.001 (Figure 2).
Animals treated with vitamins C + E repeated
the pattern observed in Group E. The average height of villi
Table 1 - Correlation between the time of biopsy and the height of villi and the number of infiltrating neutrophils in the study
groups.
G roup Height of vil l i Infiltrating Neutrophils
Spearman rho Signif icance Spearman rho Signif icance
Control 0.894 p<0.001 0.831 p<0.001
Vitamin C 0.807 p<0.001 0.786 p<0.001
Vitamin E 0.730 p<0.001 0.701 p<0.001
Vitamins C+E 0.728 p<0.001 0.686 p<0.001
Figure 2 - Average height of villi in the different treatment groups and time intervals.
Figure 1 - Correlation between time of reperfusion (horizontal
axis) and Chiu score (vertical axis).
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ranged from 332.37 + / - 48.96 in CB to 156.23 + / - 29.63
in RB60 (p <0.001) and the first statistically significant
difference occurred in BI, p <0.001 (Figure 2).
In the control biopsy, there was no statistically
significant difference between groups, with average height
of the villi ranging from 363.55 + / - 35.89 in the Control
Group and 332.37 + / - 42.00 in Group E+C (p = 0.235,
Figure 2). In BI, significant differences could be observed in
groups E (249.00 + / - 35.34, p <0.001) and C + E (240.07
+ /- 44.26) when compared to the Control Group (338.53
+ / - 45.08), p <0.001. In RB15, the only significant difference
occurred between the control group (296.87 + / - 46.13)
and Group C + E (230.99 + / -46.38), p = 0.029. In RB30,
the animals in Groups C + E and E showed statistically
significant difference when compared to the Control Group
(p <0.001), and this difference remained significant in RB45
(p = 0.020) for Group C + E and for Group E (p = 0.037),
and in RB60 for Group E (p = 0.032) and for Group C + E (p
= 0.025). These data are displayed in figure 2.
Neutrophilic infiltration
The number of infiltrating neutrophils showed a
progressive increase during the reperfusion period, with
no statistically significant difference between the Control
and Validation Groups (Table 2). The number of infiltrating
neutrophils in the mucosa and submucosa was compared
for different time intervals and treatment. We found a
statistically significant correlation between the times of
the samples and neutrophilic infiltration. The correlation
coefficient and p values   for each group are shown in
table 1.
Table 2 - Analysis of variance comparing the height of villi between the Control Group and the Validation Groups C and E in
different time intervals.
V i l l i Neutrophi l s
T ime Contro l Valid C Valid E p Contro l Valid C Valid E p
CB 363.5 346.6 341.9 0.236 0.4 0.5 0.5 0.989
BI 338.5 335.7 330.8 0.990 0.5 0.5 0.5 1.000
RB15 296.9 278.2 290.2 0.997 1.4 1.0 1.2 0.867
RB30 199.6 176.2 179.4 0.642 2.2 2.5 1.8 0.923
RB45 129.6 128.3 144.5 0.674 2.6 3.0 2.5 0.638
RB60 129.1 126.7 130.4 0.988 3.5 4.0 3.8 0.912
Figure 3 - Comparison of the number of infiltrating neutrophils
in the different treatment groups and time intervals.
Table 3 - Comparison of the number of infiltrating neutrophils among the different groups in different time intervals during
reperfusion.
Cont ro l Group C Group E
15 minutes Group C 0.25 (1.000)
Group E -0.6 (0.114) -0.625 (0.001)
Group CE -0.1 (0.984) -0.125 (0.904) 0.5 (0.033)
30 minutes Group C 0.2 (0.941)
Group E -0.6 (0.320) -0.8 (0.002)
Group CE 0.033 (1.000) -0.167 (0.899) 0.63 (0.042)
60 minutes Group C 0 (1.000)
Group E -0.85 (0.270) -0.85 (0.023)
Group CE -0.93 (0.220) -0.93 (0.020) -0.83 (0.994)
* p values are in parentheses.
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In all groups there was a progressive increase in
the number of infiltrating neutrophils. In groups Control and
E this increase was statistically significant when compared
to the control biopsy from RB30, while in Groups C and C +
E, this difference occurred from RB15 on (Figure 2).
In BI and BC there was no statistically significant
difference between groups. There was a significant
difference between Groups C and C + E when compared
to Groups E and Control in RB15 and RB30 (Table 3). In
RB45, there was no significant difference between groups
(p = 0.2087). In RB60, a significant difference was observed
between Groups C, E and C + E (Table 3).
DISCUSSION
Vitamin C has been extensively studied in I/R
injury due to its antioxidant capacity. A study using an
experimental model in rabbits with vitamin C, mannitol
and N-acetylcysteine   has been shown that the superior
mesenteric artery flow was improved by the three drugs,
but only vitamin C and mannitol had direct protective action
on gut mucosa at the histopathological exam of the small
intestine, with significant reduction of ischemia and
reperfusion injury10. These results were confirmed by
another article that showed morphological improvement
of the lesion after administration of ascorbic acid11. Another
study evaluated the role of non-enzymatic antioxidants
using the measurement of levels of malondialdehyde
(MDA) and glutathione in the intestinal mucosa, as well
as a qualitative histopathologic score. It demonstrated a
significant protective effect of vitamin C and mannitol, a
decrease of mucosal damage and accumulation of MDA.
However, the use of vitamin E showed no difference in
these parameters. The authors suggested that vitamin C
and mannitol may be useful in the prevention of intestinal
I/R injury due to its effectiveness and ease of use12. Both
articles used vitamin C intravenously and demonstrated
an appropriate protective effect. A key difference is how
the injury was evaluated, because both used qualitative
rather than quantitative measurements. We can also point
a significant difference in the doses used in this work and
in Byrka-Owczarek’s study10 (250mg/kg) from that used
by Günel12 (10mg/kg). This difference in dosage may
explain the contrasting results. Nevertheless, glycine has
the same protective profile of action when used in different
doses13.
Security in the administration of vitamin C has
also been questioned by its contradictory role in I/R injury.
In a model of liver damage by I/R, ascorbic acid was shown
to have anti- and pro-oxidant properties. After cold I/R injury,
a decreased ratio of reduced glutathione oxidation and
increased levels of lipid peroxidation and mitochondrial
swelling can be prevented by exposure to ascorbic acid at
a dose of 0.5mM, whereas a dose of 2.0mM increases
tissue injury14.
In a study of patients undergoing surgical repair
of abdominal aortic aneurysm ou infrainguinal grafts, the
preoperative administration of sodium ascorbate increased
the arteriovenous difference of lipid hydroperoxides (LH),
interleukin 6 and vascular endothelial growth factor during
ischemia. This was reflected in an increase of LH, vascular
endothelial growth factor and creatine phosphokinase during
reperfusion. The findings of these authors suggest that
sodium ascorbate can promote lipid oxidative damage
induced by iron during the ischemic phase of the operation15.
Perhaps the ascorbic acid may, at therapeutic doses, have
a negative effect on ischemia-reperfusion injury by
increasing inflammatory activity, being then indicated in
smaller quantities. The use of ascorbic acid proved to be
ineffective in preventing lipid peroxidation in serum and
intestinal mucosa16.
The administration of á-tocopherol prior to
ischemia showed both biochemical and histopathological
protective effects against I/R injury in rat livers17.
The preoperative administration of drugs has also
been demonstrated as an effective method for reducing I/
R injury. Selenium, taurine and á-tocopherol were
administered for four days before the occlusion and
reperfusion of visceral arteries in rats. The animals treated
with selenium or a combination of the three drugs showed
better mean arterial pressure of the visceral arteries and
reperfusion than the control group or other treatments18.
Oral supplementation of glutamine for a period of 48 hours
before I/R injury rendered prevention of intestinal damage
and recovery improvement19. In a clinical study20 the
preoperative use of vitamin E administered intravenously
significantly reduced liver I/R injury, with a good safety
profile, and reduction in liver enzyme concentration and
time of intensive care unit stay20. The natural antioxidant
resveratrol, administered preoperatively, also displayed
efficacy in the treatment of intestinal I/R injury in an expe-
rimental model21.
In humans, both vitamins C and E reduce
oxidative stress situations. In patients with myocardial
infarction there is a significant decrease in the levels of
vitamin E after reperfusion, which does not occur in failures
of reperfusion. The serum level of vitamin C, however, has
shown no difference between these two situations. This
provides evidence for the consumption of vitamin E during
the reperfusion phase after myocardial infarction, this being
a sign of reperfusion 22.
The number of infiltrating neutrophils in the
mucosa increases during the reperfusion period.
Polymorphonuclear neutrophils have been implicated in I/R
injury and their depletion has been tested in order to improve
intestinal damage3. Their simple counting using optical
microscopy can be an indicator of I/R injury. Both vitamins
C and E were shown to decrease lung I/R injury, but not
prevent it, because they inhibit the activation of PMN, but
not the production of reactive oxygen species from other
sources23. The association of vitamins C and E showed a
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beneficial effect on I/R injury in rat epigastric flaps, increasing
significantly the viability of the flap24. The role of neutrophil
infiltration was also demonstrated by the improvement in I/
R injury with ventilation with 100% oxygen25. In this study,
groups E and C + E had higher villi height and less neutrophil
infiltration, pointing thus to a correlation between mucosal
damage and neutrophil infiltration.
Administration of drugs before the onset of the
episode of ischemia also showed good results. Pretreatment
with oral vitamin C showed attenuation of I/R injury in an
experimental model. Its use for five days improved the ability
of muscle contraction, reduced neutrophil infiltration, tissue
edema and the burst of the neutrophils’ respiratory cycle26.
The preoperative use for a long period (five days) of L-
arginine and methyl nitro-L-arginine attenuated ischemia
and reperfusion in an experimental model in rats, with
reduced leukocyte infiltration, as assessed by biochemical
markers, such as the serum level of nitric oxide27, this effect
being observed with their use in the immediate pre-ischemic
period28.
In the present study, there was a progressive
decrease in height of villi and an increase in neutrophil
infiltration during reperfusion, as well as a significant
reduction of mucosal damage in animals treated with
vitamin E or C + E. This benefit could not be demonstrated
in animals treated with vitamin C alone. This improvement
in the height of villi was not previously demonstrated in
other works and may be due to the form of administration
of vitamin E. In most studies vitamin E is administered during
the ischemic period by subcutaneous injection. In this work,
we used the enteral route, which may have allowed an
increase in deposits of vitamin E in tissues and its more
effective action during reperfusion as retainer of ROS.
Regarding vitamin C, the experiment showed no significant
benefit of its administration alone. In this study, a significant
increase in neutrophil infiltration was observed in all groups,
but again with different responses to treatment. The groups
treated with vitamin E or C + E showed significantly fewer
neutrophils infiltrating the mucosa at the end of the study
period.
It is inferred, therefore, that preoperative nutrition
with vitamin E decreases I/R injury of the small intestine of
rats submitted to an experimental model of microvascular
flap of jejunum. Its administration is easy and safe. No
benefit could be demonstrated in this model for the use of
vitamin C.
R E S U M O
Objetivo: Avaliar o papel do pré-tratamento com antioxidantes dietéticos em um modelo experimental de lesão intestinal de
isquemia-reperfusão (I/R) em ratos. Métodos: Noventa ratos Wistar adultos machos foram utilizados. Um segmento intestinal foi
isolado baseado em seu pedículo vascular. Uma biópsia controle foi realizada e o pedículo foi seccionado e anastomosado novamen-
te, garantindo um tempo de isquemia de 60 minutos, seguido por reperfusão. Biópsias sequenciais foram realizadas ao término do
período isquêmico e a cada 15 minutos, durante a reperfusão. O tratamento consistiu de solução salina ou vitamina C ou vitamina
E ou a associação destas. Avaliações quantitativa e qualitativa das biópsias foram realizadas. Resultados:  Os grupos tratados com
vitamina E isolada ou associada com vitamina C apresentaram uma atenuação estatisticamente significativa da lesão de isquemia-
reperfusão, com diminuição da perda de altura dos vilos e menor infiltração neutrofílica ao final do estudo quando comparados ao
grupo controle e vitamina C exclusiva. Conclusão: Neste modelo experimental de isquemia-reperfusão, o pré-tratamento com
vitamina E atenuou a lesão de I/R no intestino delgado, demonstrado pela diminuição da perda de altura dos vilos e pela atenuação
da infiltração neutrofílica.
Descritores: Isquemia. Reperfusão. Traumatismo por reperfusão. Microcirurgia. Antioxidantes.
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